🇺🇸 FDA
Pipeline program

Asparaginase Erwinia chrysanthemi

RG1124788

Phase 2 small_molecule active

Quick answer

Asparaginase Erwinia chrysanthemi for B Acute Lymphoblastic Leukemia, Philadelphia Chromosome Negative is a Phase 2 program (small_molecule) at Jazz Pharmaceuticals plc with 1 ClinicalTrials.gov record(s).

Program details

Company
Jazz Pharmaceuticals plc
Indication
B Acute Lymphoblastic Leukemia, Philadelphia Chromosome Negative
Phase
Phase 2
Modality
small_molecule
Status
active

Clinical trials